Hypha Labs, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
Hypha Labs, Inc. (FUNI) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 310.06 thousand shares for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2026-08-14
- Hypha Labs, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2026-06-30 was 0.00 shares.
- Hypha Labs, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2026-03-31 was 0.00 shares.
- Hypha Labs, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-12-31 was 310.06K shares.
- Hypha Labs, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-09-30 was 390.25K shares.
- Hypha Labs, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2025 was 2.39M shares.
- Hypha Labs, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2023 was 13.89M shares.
- Hypha Labs, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2020 was 1.50M shares.
- Hypha Labs, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2018 was 1.08M shares, a 38.29% decline from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-14 | 310.06K shares 10-Q · filed 2026-08-14 | 700.31K shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | 310.06K shares 10-Q · filed 2026-05-15 | 700.31K shares derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-12-31 | 310.06K shares 10-Q · filed 2026-02-17 | 700.31K shares derived: sum of 2 quarters · filed 2026-02-17 | ||
| 2025-09-30 | 390.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-15 | 2.39M shares 10-K · filed 2026-01-15 | ||
| 2025-06-30 | 2.00M shares 10-Q · filed 2025-08-21 | |||
| 2023-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-13 | 0.00 shares derived: sum of 2 quarters · filed 2025-01-13 | 0.00 shares derived: sum of 3 quarters · filed 2025-01-13 | 13.89M shares 10-K · filed 2025-01-13 |
| 2023-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-18 | 0.00 shares derived: sum of 2 quarters · filed 2023-08-18 | 13.89M shares 10-Q · filed 2023-08-18 | |
| 2023-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-26 | 13.89M shares 10-Q · filed 2023-05-26 | ||
| 2022-12-31 | 13.89M shares 10-Q · filed 2023-02-14 | |||
| 2020-09-30 | 1.50M shares 10-K · filed 2021-12-29 | |||
| 2018-09-30 | 1.08M shares 10-K · filed 2019-12-31 | |||
| 2017-09-30 | 1.75M shares 10-K · filed 2018-12-27 |